FDA Inspection 1067106 — Netaji Subhash Chandra Bose Cancer Hospital
The FDA completed an inspection of Netaji Subhash Chandra Bose Cancer Hospital on August 16, 2018 in Kolkata. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kolkata (India)
Additional Details
Clinical BA/BE